Supply of Colchicine
Department of Health and Social Care (T&T)contractFind a Tender ↗Ref ocds-h6vhtk-02a35432014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
5
Lots
1
5 awarded
Published
07 Apr 2021
Description
The Department of Health and Social Care (DHSC) has awarded a contract for the supply of Colchicine for Covid-19.
Scope
- Reference
- CM/EMP/21/25161
- Commercial tool
- Standalone contract
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| — | — | price | — |
Submission & procedure
- Procedure
- Award procedure without prior publication of a call for competition
Award details· 5 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Award 1· 1 supplier
Awarded —
Award value
—
Award 2· 1 supplier
Awarded —
Award value
—
Award 3· 1 supplier
Awarded —
Award value
—
Award 4· 1 supplier
Awarded —
Award value
—
Award 5· 1 supplier
Awarded —
Award value
—
Other contracts from Department of Health and Social Care (T&T)
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Accord-UK Ltd· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 | contract | — | 09 Jun 2026 |
| NHS National Generics Pharmaceuticals - Supply Chain Resilience | contract | — | 01 May 2026 |
| NHS National Branded Interim - 1 June 2026 | contract | — | 16 Apr 2026 |
| NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide | contract | — | 26 Mar 2026 |
| Generic Drugs – Injections/Infusions 2 | contract | — | 03 Mar 2026 |
| NHS National Framework for Transition Products (Nintedanib and Dalbavancin) | contract | — | 25 Feb 2026 |
| Transitional Drugs 6 | contract | — | 04 Feb 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 14 Jan 2026 |
| NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin | contract | — | 26 Nov 2025 |
| NHS National Framework for Generics Housekeeping | contract | — | 11 Nov 2025 |